PALO ALTO, Calif., June 14 (Bernama-BUSINESS WIRE) — Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced it has purchased the remaining shares of Guardant Health AMEA, Inc., held by SoftBank and its affiliates, giving the company full control over operations throughout the Asia, Middle East and Africa region.
More than half of the world’s estimated new cancer cases come from Asia, Middle East and Africa (AMEA).¹ This acquisition will allow Guardant Health to directly address the growing cancer burden in the region by accelerating the adoption of the company’s blood tests and services used by healthcare providers to detect and manage cancer across all stages of the disease.
http://mrem.bernama.com/viewsm.php?idm=43414